Compare TPL & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TPL | WST |
|---|---|---|
| Founded | 1888 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.3B | 25.6B |
| IPO Year | 2020 | 2004 |
| Metric | TPL | WST |
|---|---|---|
| Price | $433.10 | $358.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $639.00 | $325.86 |
| AVG Volume (30 Days) | 391.0K | ★ 682.3K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | ★ 0.55% | 0.30% |
| EPS Growth | N/A | ★ 1.49 |
| EPS | ★ 2.07 | 1.92 |
| Revenue | $798,190,000.00 | ★ $2,886,900,000.00 |
| Revenue This Year | $29.67 | $6.76 |
| Revenue Next Year | $14.69 | $6.22 |
| P/E Ratio | $201.17 | ★ $187.57 |
| Revenue Growth | ★ 13.09 | 1.95 |
| 52 Week Low | $280.95 | $223.83 |
| 52 Week High | $1,048.88 | $367.66 |
| Indicator | TPL | WST |
|---|---|---|
| Relative Strength Index (RSI) | 63.15 | 57.76 |
| Support Level | $363.85 | $349.41 |
| Resistance Level | $449.45 | $367.66 |
| Average True Range (ATR) | 15.21 | 7.87 |
| MACD | 2.42 | -1.68 |
| Stochastic Oscillator | 96.78 | 50.77 |
Texas Pacific Land Corp is mainly engaged in the sales and leases of land owned, retaining oil and gas royalties, and the overall management of the land owned. The group operates its business in two reportable segments: Land and Resource Management and Water Service and Operations. The Land and Resource Management segment, which generates maximum revenue, focuses on managing its several surface acres of land and its oil and gas royalty interests, principally concentrated in the Permian Basin. The revenue streams of this segment consist of royalties from oil and gas, revenues from easements and commercial leases, and land and material sales. The Water Services and Operations segment encompasses the business of providing a full-service water offering to operators in the Permian Basin.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.